Global Next Generation Sequencing Ngs Market
Marktgröße in Milliarden USD
CAGR :
% 
 Prognosezeitraum |
2024 –2031 |
 Marktgröße (Basisjahr) | USD 13.88 Billion |
 Marktgröße (Prognosejahr) | USD 40.78 Billion |
 CAGR |
% |
| Wichtige Marktteilnehmer |
|
Global Next Generation Sequencing (NGS) Market, By Product & Service (Consumables, Services, and Instruments), Technology (Sequencing by Synthesis (SBS), Sequencing by Ligation (SBL), and Others), Application (Pharmaceuticals Microbiology, Drug & Biomarker Discovery, Diagnostics, Precision Medicine, Agricultural & Animal Research, Food Pathogen Screening, and Others), End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Clinics, Clinical Laboratories, Contract Research Organizations (CROS), and Others), Distribution Channel (Direct Tender, Retail Sales, and Others) - Industry Trends and Forecast to 2031.
Next Generation Sequencing (NGS) Market Analysis and Size
The global next generation sequencing (NGS) market is driven by the increasing demand for personalized medicine and the growing adoption of NGS technologies in clinical diagnostics and research applications. However, one restraint for market growth is the high cost associated with NGS procedures, limiting its accessibility in developing regions. An opportunity in this market lies in the advancements in NGS technologies, such as improved data analysis tools and faster sequencing platforms, which can enhance the efficiency and accuracy of sequencing processes. One challenge is the need for standardized protocols and regulations for NGS-based tests to ensure consistency and reliability across different laboratories and healthcare settings.
Data Bridge Market Research analyzes that the global next generation sequencing (NGS) market is growing with a CAGR of 15.1% in the forecast period of 2024 to 2031 and is expected to reach USD 40.78 billion by 2031 from USD 13.88 billion in 2023.
|
Report Metric |
Details |
|
Forecast Period |
2024 to 2031 |
|
Base Year |
2023 |
|
Historic Years |
2022 (Customizable 2016-2021) |
|
Quantitative Units |
Revenue in USD Billion |
|
Segments Covered |
Product & Service (Consumables, Services, and Instruments), Technology (Sequencing by Synthesis (SBS), Sequencing by Ligation (SBL), and Others), Application (Pharmaceuticals Microbiology, Drug & Biomarker Discovery, Diagnostics, Precision Medicine, Agricultural & Animal Research, Food Pathogen Screening and Others), End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Clinics, Clinical Laboratories, Contract Research Organizations (CROS), and Others), Distribution Channel (Direct Tender, Retail Sales, and Others) |
|
Countries Covered |
U.S., Canada, and Mexico, U.K., Germany, France, Spain, Italy, Belgium, Russia, Switzerland, Netherlands, Turkey, rest of Europe, China, Australia, Japan, India, Singapore, South Korea, Malaysia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Brazil, Argentina, and rest of South America, South Africa, Egypt, Saudi Arabia, U.A.E., Israel, and rest of Middle East and Africa |
|
Market Players Covered |
Illumina, Inc., Thermo Fisher Scientific Inc., QIAGEN, Merck KGaA, Charles River Laboratories, Revvity, Promega Corporation., Agilent Technologies, Inc., Takara Bio Inc., Eurofins Scientific, Hamilton Company, BGI, Azenta US, Inc., Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., PacBio., Macrogen, Inc., Gilson Incorporated, New England Biolabs, Oxford Nanopore Technologies plc., LGC Biosearch Technologies, PCR Biosystems, ACT Genomics, Quantabio, DNASTAR, and NimaGen. among others |
Market Definition
Next Generation Sequencing (NGS), also identified as high-throughput sequencing, is a powerful technology used for rapidly sequencing DNA and RNA. Unlike traditional sanger sequencing, which is slower and more expensive, NGS allows for the simultaneous sequencing of millions of DNA fragments, enabling researchers to quickly and efficiently analyze large genomes, identify genetic variations, and study gene expression patterns. NGS has revolutionized genomics research, enabling new visions into the genetic basis of diseases, the diversity of microbial communities, and the evolution of species.
Global Next Generation Sequencing (NGS) Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail as below:
Drivers
- Increase in the Adoption of Genome-Focused Pharmacology
The increasing adoption of genomic pharmacology is acting as a major driver for the global next generation sequencing (NGS) market, transforming the landscape of personalized medicine and targeted therapies. As healthcare providers recognize the value of tailoring treatments based on individual genetic profiles, the demand for high-throughput, accurate genomic sequencing has surged. NGS technologies enable comprehensive analysis of a patient's genome, allowing for precise identification of genetic variants that influence drug response, resistance, and potential adverse effects. This level of personalized insight guides clinicians in selecting the most in effect and safe treatments for each patient, improving outcomes and reducing trial-and-error prescribing. As a result, the NGS market is expanding rapidly, fueled by the growing adoption of genomic pharmacology across various medical fields and its potential to revolutionize patient care and outcomes.
- Wide Product Portfolio Offered by Major Players
A wide product portfolio offered by market players is a key driver for the growth of the global next generation sequencing (NGS) market, as it provides customers with a comprehensive variety of solutions to meet diverse research and clinical needs. By offering a variety of NGS platforms, consumables, and software, market players can cater to different levels of research complexity, throughput requirements, and budgetary constraints. This versatility agrees researchers and clinicians to select the most appropriate tools for their specific applications, whether it's whole-genome sequencing, targeted sequencing, or transcriptome analysis. Additionally, a broad portfolio can include specialized offerings such as kits for cancer genomics, microbiome studies, and rare disease research, further appealing to a wide range of customers across academia, healthcare, and industry.
Opportunity
- Increasing Advancement in NGS Technology
Enhanced sequencing speed, accuracy, scalability, and cost-effectiveness, have significantly expanded the applications of NGS across various fields such as genomics, oncology, and infectious diseases. This expansion of applications has not only increased the demand for NGS technologies but has also opened up new markets. In addition, the decreasing cost of sequencing has made NGS more accessible to researchers, clinicians, and patients, further driving its adoption in clinical diagnostics and personalized medicine. Furthermore, ongoing technological innovations, such as the development of long-read sequencing technologies and portable sequencing devices, continue to recover the performance and usability of NGS platforms, enhancing their value proposition for customers.
Restraint/Challenge
- Complexity During Implementation of NGS in the Clinical Lab
The implementation of next generation sequencing (NGS) in clinical laboratories faces several restraints that can impede the growth of the NGS market. One major restraint is the complexity and variability of NGS data. The huge amount of genetic data generated requires sophisticated bioinformatics tools for analysis and interpretation. Clinical labs must invest in these resources and skilled personnel to ensure accurate and actionable results, which can be a barrier to adoption. Another restraint is the demand for advanced instrumentation and specialized equipment for NGS. These instruments can be expensive, and maintaining them requires a significant investment in infrastructure and technical expertise. Smaller clinical labs may struggle to justify the cost of these investments, limiting the widespread implementation of NGS.
Recent Developments
- In April 2024, Merck KGaA has introduced the industry's first all-in-one, validated genetic stability assay. The Aptegra CHO genetic stability assay uses whole genome sequencing and bioinformatics to speed up biosafety testing for clients, facilitating their transition to commercial production. This innovation will help Merck KGaA streamline biosafety testing for clients, enabling faster transitions to commercial production and enhancing their competitiveness in the market
- In January 2024, QIAGEN has upgraded its QIAGEN CLC Genomics Workbench Premium with LightSpeed technology to include support for next-generation sequencing (NGS) in somatic cancer secondary analysis. This software accelerator efficiently converts raw sequencing data from FASTQ files to interpretable lists of genetic variants in VCF files at a remarkably low cost and high speed. This upgrade strengthens QIAGEN's offering, providing customers with a faster, cost-effective solution for somatic cancer NGS analysis, enhancing their competitiveness
- In January 2024, Beckman Coulter, Inc. has partnered with Polycarbin, a trailblazer in sustainable laboratory solutions. Together, they aim to revolutionize lab sustainability for liquid handling automation plastics. This collaboration merges Beckman Coulter Life Sciences' expertise in automated liquid handling with Polycarbin's circular economy platform, focusing on sustainability in laboratory plastics
- In November 2023, QIAGEN and DNA Labs International have collaborated to solve two decades-old cold cases using QIAGEN's ForenSeq Kintelligence System for forensic genetic genealogy, in conjunction with the GEDmatch PRO database. This highlights the effectiveness and increasing adoption of this approach to human identification. This will result in effectiveness of QIAGEN's forensic genetic genealogy solutions, potentially boosting their adoption and sales in the forensic market
- In November 2023, Beckman Coulter, Inc. has entered into a collaboration agreement with Pillar Biosciences, a developer and distributor of IVD & RUO NGS testing solutions using their proprietary SLIMamp technology. As part of the agreement, Pillar Biosciences will create a series of applications for use on the Biomek NGeniuS Next Generation Library Preparation System. This collaboration will enhance Beckman Coulter's offerings by integrating Pillar Biosciences' advanced NGS testing solutions, benefiting cancer patients through improved precision therapy selection
- In November 2023, QIAGEN and Element Biosciences, Inc. have announced a strategic partnership to provide comprehensive next-generation sequencing (NGS) workflows for the Element AVITI System, an innovative sequencing platform. This partnership will expand QIAGEN's portfolio of NGS workflows and strengthen its position in the genomics market
- In October 2023, Beckman Coulter, Inc. and 10x Genomics have partnered to enhance automation solutions for single-cell assay workflows. Under this collaboration, 10x Genomics will develop Chromium Single Cell kits tailored for use with Beckman Coulter Life Sciences' Biomek i7 Automated Liquid Handler. This customized application aims to automate 10x Genomics' single-cell library preparation, ensuring high-quality, large-scale production of finished libraries ready for sequencing. This partnership will enable Beckman Coulter to offer enhanced automation solutions for single-cell assays, providing customers with streamlined workflows and improved efficiency
- In October 2023, Azenta US, Inc. announced that GENEWIZ Multiomics and Synthesis Solutions from Azenta Life Sciences will host GENEWIZ Week from November 6-10, 2023. The event will include virtual workshops, promotions, and a grant program for genomics research excellence. Hosting GENEWIZ Week enhanced Azenta's brand visibility, attract new customers, and foster collaborations in the genomics research community, ultimately driving growth and innovation
- In September 2023, Charles River Laboratories and PathoQuest SAS, a provider of next-generation sequencing (NGS) testing services for biopharmaceuticals, announced that they have jointly published groundbreaking research in Vaccine. This study highlighted the superior viral contaminant detection capabilities of PathoQuest's proprietary, good manufacturing practice (GMP) grade NGS-based assay compared to in vivo assays. This achievement will enhance the company's reputation and position it as a leader in biopharmaceutical testing, potentially attracting more clients seeking advanced and reliable testing solutions
- In May 2023, Charles River Laboratories has introduced Accugenix Next Generation Sequencing for Bacterial Identification and Fungal Identification (Accugenix NGS). This technology sequences millions of individual DNA fragments from a sample, offering pharmaceutical and personal care manufacturers crucial microbial control information. The new technology enhances the company's services, offering pharmaceutical and personal care manufacturers advanced microbial control solutions that improve product quality and regulatory compliance
Global Next Generation Sequencing (NGS) Market Scope
The global next generation sequencing (NGS) market is segmented into five notable segments based on product & service, technology, application, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the differences in your target markets.
Product & Service
- Consumables
- Services
- Instruments
On the basis of product & service, the global next generation sequencing (NGS) market is segmented into consumables, services, and instruments.
Technology
- Sequencing by Synthesis (SBS)
- Sequencing by Ligation (SBL)
- Others
On the basis of technology, the global next generation sequencing (NGS) market is segmented into Sequencing by Synthesis (SBS), Sequencing by Ligation (SBL), and others.
Application
- Pharmaceuticals Microbiology
- Drug & Biomarker Discovery
- Diagnostics
- Precision Medicine
- Agricultural & Animal Research
- Food Pathogen Screening
- Others
On the basis of application, the global next generation sequencing (NGS) market is segmented into pharmaceuticals microbiology, drug & biomarker discovery, diagnostics, precision medicine, agricultural & animal research, food pathogen screening, and others.
End user
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Hospitals & Clinics
- Clinical Laboratories
- Contract Research Organizations (CROS)
- Others
On the basis of end user, the global next generation sequencing (NGS) market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, hospitals & clinics, clinical laboratories, Contract Research Organizations (CROS), and others.
Distribution channel
- Direct tender
- Retail sales
- Others
On the basis of distribution channel, the global next generation sequencing (NGS) market is segmented into direct tender, retail sales, and others.
Global Next Generation Sequencing (NGS) Market Regional Analysis/Insights
The global next generation sequencing (NGS) market is analyzed, and market size insights and trends are provided by based on product & service, technology, application, end user, and distribution channel as referenced above.
The countries covered in this global next generation sequencing (NGS) market report are U.S., Canada, and Mexico, U.K., Germany, France, Spain, Italy, Belgium, Russia, Switzerland, Netherlands, Turkey, rest of Europe, China, Australia, Japan, India, Singapore, South Korea, Malaysia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Brazil, Argentina, and rest of South America, South Africa, Egypt, Saudi Arabia, U.A.E., Israel, and rest of Middle East and Africa.
North America is expected to dominate the global next generation sequencing (NGS) market due to factors such as the presence of a huge number of key market players, high adoption of NGS technologies in research and clinical applications, and favorable government initiatives and funding supporting genomics research.
U.S. is expected to dominate in the North America next generation sequencing (NGS) market due to factors such as the presence of a large number of NGS technology providers, significant investments in genomic research, and a supportive regulatory environment promoting the adoption of NGS in clinical and research settings.
U.K. is expected to dominate in the Europe next generation sequencing (NGS) market due to its advanced healthcare infrastructure, strong government support for genomic research, and a well-established market for NGS technologies and services.
China is expected to dominate in the Asia-Pacific next generation sequencing (NGS) market due to its large population, increasing adoption of precision medicine, government initiatives to promote genomics research, and a growing number of NGS technology providers in the region.
The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Next Generation Sequencing (NGS) Market Share Analysis
The global next generation sequencing (NGS) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus on the global next generation sequencing (NGS) market.
Some of the major players operating in the global next generation sequencing (NGS) market are Illumina, Inc., Thermo Fisher Scientific Inc., QIAGEN, Merck KGaA, Charles River Laboratories, Revvity, Promega Corporation., Agilent Technologies, Inc., Takara Bio Inc., Eurofins Scientific, Hamilton Company, BGI, Azenta US, Inc., Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., PacBio., Macrogen, Inc., Gilson Incorporated, New England Biolabs, Oxford Nanopore Technologies plc., LGC Biosearch Technologies, PCR Biosystems, ACT Genomics, Quantabio, DNASTAR, and NimaGen. among others.
SKU-
Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud
- Interaktives Datenanalyse-Dashboard
- Unternehmensanalyse-Dashboard für Chancen mit hohem Wachstumspotenzial
- Zugriff für Research-Analysten für Anpassungen und Abfragen
- Konkurrenzanalyse mit interaktivem Dashboard
- Aktuelle Nachrichten, Updates und Trendanalyse
- Nutzen Sie die Leistungsfähigkeit der Benchmark-Analyse für eine umfassende Konkurrenzverfolgung
Inhaltsverzeichnis
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET APPLICATION COVERAGE GRID
2.8 PRODUCT LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTERS FIVE FORCES
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 INCREASE IN THE ADOPTION OF GENOME-FOCUSED PHARMACOLOGY
5.1.2 WIDE PRODUCT PORTFOLIO OFFERED BY MAJOR PLAYERS
5.1.3 USE OF NEXT GENERATION SEQUENCING IN DRUG DEVELOPMENT
5.1.4 INCREASE TREND TOWARDS PERSONALIZED MEDICATION
5.2 RESTRAINTS
5.2.1 HIGH COST OF INSTALLATION AND MAINTENANCE OF EQUIPMENT’S IN THE LABORATORY
5.2.2 COMPLEXITY DURING IMPLEMENTATION OF NGS IN THE CLINICAL LAB
5.3 OPPORTUNITIES
5.3.1 STRATEGIC INITIATIVES BY THE KEY MARKET PLAYERS
5.3.2 INCREASING ADVANCEMENT IN NGS TECHNOLOGY
5.3.3 INCREASING APPLICATIONS OF NGS IN CLINICAL DIAGNOSTICS
5.4 CHALLENGES
5.4.1 LACK OF SKILLED PROFESSIONALS TO PERFORM NGS
5.4.2 DATA PRIVACY AND SECURITY
6 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT AND SERVICE
6.1 OVERVIEW
6.2 CONSUMABLES
6.2.1 LIBRARY PREPARATION CONSUMABLES
6.2.2 SAMPLE PREPARATION CONSUMABLES
6.3 SERVICES
6.3.1 SEQUENCING SERVICES
6.3.1.1 RNA SEQUENCING
6.3.1.2 DNA SEQUENCING
6.3.1.2.1 WHOLE GENOME SEQUENCING
6.3.1.2.2 WHOLE EXOME SEQUENCING
6.3.1.2.3 TARGETED SEQUENCING
6.3.1.2.4 CHIP SEQUENCING
6.3.1.2.5 DE NOVO SEQUENCING
6.3.1.2.6 OTHERS
6.3.2 DATA MANAGEMENT SERVICES
6.3.2.1 NGS STORAGE, MANAGEMENT AND CLOUD COMPUTING SOLUTIONS
6.3.2.2 NGS DATA ANALYSIS SOFTWARE AND WORKBENCHES
6.3.2.3 NGS DATA ANALYSIS SERVICES
6.4 INSTRUMENTS
6.4.1 BENCHTOP
6.4.2 STANDALONE
6.4.2.1 AUTOMATED
6.4.2.2 SEMI-AUTOMATED
6.4.2.3 MANUAL
6.4.2.3.1 WORKSTATION/PLATFORM
6.4.2.3.2 SYSTEM
7 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY
7.1 OVERVIEW
7.2 SEQUENCING BY SYNTHESIS (SBS)
7.2.1 PYROSEQUENCING
7.2.2 ION SEMI CONDUCTOR SEQUENCING
7.2.3 NANOPORE SEQUENCING
7.2.4 SINGLE-MOLECULE-REAL-TIME SEQUENCING (SMRT)
7.3 SEQUENCING BY LIGATION (SBL)
7.4 OTHERS
8 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 PHARMACEUTICALS MICROBIOLOGY
8.2.1 MICROBIAL IDENTIFICATION/DETECTION
8.2.2 TARGETED SEQUENCING
8.2.3 CELL LINE CHARACTERIZATION
8.2.4 ANTIMICROBIAL RESISTANCE AND PREDICTING ANTIMICROBIAL SUSCEPTIBILITIES
8.2.5 STRAIN SUBTYPING
8.2.6 OTHERS
8.2.6.1 SEQUENCING BY SYNTHESIS (SBS)
8.2.6.2 SEQUENCING BY LIGATION (SBL)
8.2.6.3 OTHERS
8.3 DRUG & BIOMARKER DISCOVERY
8.3.1 SEQUENCING BY SYNTHESIS (SBS)
8.3.2 SEQUENCING BY LIGATION (SBL)
8.3.3 OTHERS
8.4 DIAGNOSTICS
8.4.1 CANCER DIAGNOSTICS
8.4.2 INFECTIOUS DISEASE DIAGNOSTICS
8.4.3 REPRODUCTIVE HEALTH DIAGNOSTICS
8.4.4 OTHER DIAGNOSTIC APPLICATIONS
8.4.4.1 SEQUENCING BY SYNTHESIS (SBS)
8.4.4.2 SEQUENCING BY LIGATION (SBL)
8.4.5 OTHERS
8.5 PRECISION MEDICINE
8.5.1 SEQUENCING BY SYNTHESIS (SBS)
8.5.2 SEQUENCING BY LIGATION (SBL)
8.5.3 OTHERS
8.6 AGRICULTURAL & ANIMAL RESEARCH
8.6.1 SEQUENCING BY SYNTHESIS (SBS)
8.6.2 SEQUENCING BY LIGATION (SBL)
8.6.3 OTHERS
8.7 FOOD PATHOGEN SCREENING
8.8 OTHERS
9 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER
9.1 OVERVIEW
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
9.3 ACADEMIC & RESEARCH INSTITUTES
9.4 HOSPITALS & CLINICS
9.5 CLINICAL LABORATORIES
9.6 CONTRACT RESEARCH ORGANIZATIONS (CROS)
9.7 OTHERS
10 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL
10.1 OVERVIEW
10.2 DIRECT TENDER
10.3 RETAIL SALES
10.3.1 OFFLINE
10.3.2 ONLINE
10.4 OTHERS
11 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION
11.1 OVERVIEW
11.2 NORTH AMERICA
11.2.1 U.S.
11.2.2 CANADA
11.2.3 MEXICO
11.3 EUROPE
11.3.1 U.K.
11.3.2 GERMANY
11.3.3 FRANCE
11.3.4 SPAIN
11.3.5 ITALY
11.3.6 BELGIUM
11.3.7 RUSSIA
11.3.8 SWITZERLAND
11.3.9 NETHERLANDS
11.3.10 TURKEY
11.3.11 REST OF EUROPE
11.4 ASIA-PACIFIC
11.4.1 CHINA
11.4.2 AUSTRALIA
11.4.3 JAPAN
11.4.4 INDIA
11.4.5 SINGAPORE
11.4.6 SOUTH KOREA
11.4.7 MALAYSIA
11.4.8 THAILAND
11.4.9 INDONESIA
11.4.10 PHILIPPINES
11.4.11 REST OF ASIA-PACIFIC
11.5 SOUTH AMERICA
11.5.1 BRAZIL
11.5.2 ARGENTINA
11.5.3 REST OF SOUTH AMERICA
11.6 MIDDLE EAST AND AFRICA
11.6.1 SOUTH AFRICA
11.6.2 SAUDI ARABIA
11.6.3 U.A.E.
11.6.4 ISRAEL
11.6.5 REST OF MIDDLE EAST AND AFRICA
12 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: GLOBAL
12.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
12.3 COMPANY SHARE ANALYSIS: EUROPE
12.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
13 SWOT ANALYSIS
14 COMPANY PROFILING
14.1 ILLUMINA, INC.
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUEANALYSIS
14.1.3 COMPANY SHARE ANALYSIS
14.1.4 PRODUCT PORTFOLIO
14.1.5 RECENT DEVELOPMENTS
14.2 THERMO FISHER SCIENTIFIC INC.
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 COMPANY SHARE ANALYSIS
14.2.4 PRODUCT PORTFOLIO
14.2.5 RECENT DEVELOPMENTS
14.3 QIAGEN
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 COMPANY SHARE ANALYSIS
14.3.4 PRODUCT PORTFOLIO
14.3.5 RECENT DEVELOPMENTS
14.4 MERCK KGAA
14.4.1 COMPANY SNAPSHOT
14.4.2 REVENUE ANALYSIS
14.4.3 COMPANY SHARE ANALYSIS
14.4.4 PRODUCT PORTFOLIO
14.4.5 RECENT DEVELOPMENT
14.5 CHARLES RIVER LABORATORIES
14.5.1 COMPANY SNAPSHOT
14.5.2 REVENUE ANALYSIS
14.5.3 COMPANY SHARE ANALYSIS
14.5.4 PRODUCT PORTFOLIO
14.5.5 RECENT DEVELOPMENTS
14.6 ACT GENOMICS
14.6.1 COMPANY SNAPSHOT
14.6.2 PRODUCT PORTFOLIO
14.6.3 RECENT DEVELOPMENTS
14.7 AGILENT TECHNOLOGIES, INC.
14.7.1 COMPANY SNAPSHOT
14.7.2 REVENUE ANALYSIS
14.7.3 PRODUCT PORTFOLIO
14.7.4 RECENT DEVELOPMENT
14.8 AZENTA US, INC.
14.8.1 COMPANY SNAPSHOT
14.8.2 REVENUE ANALYSIS
14.8.3 PRODUCT PORTFOLIO
14.8.4 RECENT DEVELOPMENT
14.9 BECKMAN COULTER, INC.
14.9.1 COMPANY SNAPSHOT
14.9.2 PRODUCT PORTFOLIO
14.9.3 RECENT DEVELOPMENTS
14.1 BIO-RAD LABORATORIES, INC.
14.10.1 COMPANY SNAPSHOT
14.10.2 REVENUE ANALYSIS
14.10.3 PRODUCT PORTFOLIO
14.10.4 RECENT DEVELOPMENTS
14.11 BGI (A SUBSIDIAIRY OF BGI GROUP) (2024)
14.11.1 COMPANY SNAPSHOT
14.11.2 PRODUCT PORTFOLIO
14.11.3 RECENT DEVELOPMENT
14.12 DNASTAR
14.12.1 COMPANY SNAPSHOT
14.12.2 PRODUCT PORTFOLIO
14.12.3 RECENT DEVELOPMENT
14.13 EUROFINS SCIENTIFIC
14.13.1 COMPANY SNAPSHOT
14.13.2 REVENUE ANALYSIS
14.13.3 PRODUCT PORTFOLIO
14.13.4 RECENT DEVELOPMENTS
14.14 GILSON INCORPORATED
14.14.1 COMPANY SNAPSHOT
14.14.2 PRODUCT PORTFOLIO
14.14.3 RECENT DEVELOPMENT
14.15 HAMILTON COMPANY
14.15.1 COMPANY SNAPSHOT
14.15.2 PRODUCT PORTFOLIO
14.15.3 RECENT DEVELOPMENT
14.16 LGC BIOSEARCH TECHNOLOGIES
14.16.1 COMPANY SNAPSHOT
14.16.2 PRODUCT PORTFOLIO
14.16.3 RECENT DEVELOPMENTS
14.17 MACROGEN, INC.
14.17.1 COMPANY SNAPSHOT
14.17.2 REVENUE ANALYSIS
14.17.3 PRODUCT PORTFOLIO
14.17.4 RECENT DEVELOPMENT
14.18 NEW ENGLAND BIOLABS
14.18.1 COMPANY SNAPSHOT
14.18.2 PRODUCT PORTFOLIO
14.18.3 RECENT DEVELOPMENT
14.19 NIMAGEN
14.19.1 COMPANY SNAPSHOT
14.19.2 PRODUCT PORTFOLIO
14.19.3 RECENT DEVELOPMENT
14.2 OXFORD NANOPORE TECHNOLOGIES PLC.
14.20.1 COMPANY SNAPSHOT
14.20.2 REVENUE ANALYSIS
14.20.3 PRODUCT PORTFOLIO
14.20.4 RECENT DEVELOPMENTS
14.21 PACBIO.
14.21.1 COMPANY SNAPSHOT
14.21.2 REVENUE ANALYSIS
14.21.3 PRODUCT PORTFOLIO
14.21.4 RECENT DEVELOPMENTS
14.22 PCR BIOSYSTEMS
14.22.1 COMPANY SNAPSHOT
14.22.2 PRODUCT PORTFOLIO
14.22.3 RECENT DEVELOPMENTS
14.23 PROMEGA CORPORATION.
14.23.1 COMPANY SNAPSHOT
14.23.2 PRODUCT PORTFOLIO
14.23.3 RECENT DEVELOPMENTS
14.24 QUANTABIO
14.24.1 COMPANY SNAPSHOT
14.24.2 PRODUCT PORTFOLIO
14.24.3 RECENT DEVELOPMENT
14.25 REVVITY
14.25.1 COMPANY SNAPSHOT
14.25.2 REVENUE ANALYSIS
14.25.3 PRODUCT PORTFOLIO
14.25.4 RECENT DEVELOPMENT
14.26 TAKARA BIO INC.
14.26.1 COMPANY SNAPSHOT
14.26.2 REVENUE ANALYSIS
14.26.3 PRODUCT PORTFOLIO
14.26.4 RECENT DEVELOPMENTS
15 QUESTIONNAIRE
16 RELATED REPORTS
Tabellenverzeichnis
TABLE 1 INSTRUMENT COST PER RUN
TABLE 2 PLATFORM /COMPANY COST PER RUN
TABLE 3 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 4 GLOBAL CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 5 GLOBAL CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 6 GLOBAL SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 7 GLOBAL SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 8 GLOBAL SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 9 GLOBAL SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 10 GLOBAL DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 11 GLOBAL INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 12 GLOBAL INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 13 GLOBAL INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 14 GLOBAL INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 15 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 16 GLOBAL CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 17 GLOBAL SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 18 GLOBAL SEQUENCING BY LIGATION (SBL) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 19 GLOBAL OTHERS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 20 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 21 GLOBAL PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 22 GLOBAL PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 23 GLOBAL PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 24 GLOBAL DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 25 GLOBAL DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 26 GLOBAL DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 27 GLOBAL DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 28 GLOBAL DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 29 GLOBAL PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 30 GLOBAL PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 31 GLOBAL AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 32 GLOBAL AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 33 GLOBAL FOOD PATHOGEN SCREENING IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 34 GLOBAL OTHERS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 35 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 36 GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 37 GLOBAL ACADEMIC & RESEARCH INSTITUTES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 38 GLOBAL HOSPITALS & CLINICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 39 GLOBAL CLINICAL LABORATORIES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 40 GLOBAL CONTRACT RESEARCH ORGANIZATIONS (CROS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 41 GLOBAL OTHERS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 42 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 43 GLOBAL DIRECT TENDER IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 44 GLOBAL RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 45 GLOBAL RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 46 GLOBAL OTHERS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 47 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 48 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
TABLE 49 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 50 NORTH AMERICA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 51 NORTH AMERICA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 52 NORTH AMERICA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 53 NORTH AMERICA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 54 NORTH AMERICA DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 55 NORTH AMERICA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 56 NORTH AMERICA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 57 NORTH AMERICA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 58 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 59 NORTH AMERICA SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 60 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 61 NORTH AMERICA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 62 NORTH AMERICA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 63 NORTH AMERICA DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 64 NORTH AMERICA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 65 NORTH AMERICA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 66 NORTH AMERICA PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 67 NORTH AMERICA AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 68 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 69 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 70 NORTH AMERICA RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 71 U.S. NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 72 U.S. CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 73 U.S. SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 74 U.S. SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 75 U.S. SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 76 U.S. DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 77 U.S. INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 78 U.S. INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 79 U.S. INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 80 U.S. NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 81 U.S. SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 82 U.S. NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 83 U.S. PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 84 U.S. PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 85 U.S. DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 86 U.S. DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 87 U.S. DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 88 U.S. PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 89 U.S. AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 90 U.S. NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 91 U.S. NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 92 U.S. RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 93 CANADA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 94 CANADA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 95 CANADA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 96 CANADA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 97 CANADA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 98 CANADA DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 99 CANADA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 100 CANADA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 101 CANADA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 102 CANADA NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 103 CANADA SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 104 CANADA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 105 CANADA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 106 CANADA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 107 CANADA DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 108 CANADA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 109 CANADA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 110 CANADA PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 111 CANADA AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 112 CANADA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 113 CANADA NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 114 CANADA RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 115 MEXICO NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 116 MEXICO CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 117 MEXICO SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 118 MEXICO SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 119 MEXICO SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 120 MEXICO DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 121 MEXICO INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 122 MEXICO INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 123 MEXICO INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 124 MEXICO NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 125 MEXICO SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 126 MEXICO NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 127 MEXICO PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 128 MEXICO PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 129 MEXICO DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 130 MEXICO DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 131 MEXICO DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 132 MEXICO PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 133 MEXICO AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 134 MEXICO NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 135 MEXICO NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 136 MEXICO RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 137 EUROPE NEXT GENERATION SEQUENCING (NGS) MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
TABLE 138 EUROPE NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 139 EUROPE CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 140 EUROPE SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 141 EUROPE SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 142 EUROPE SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 143 EUROPE DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 144 EUROPE INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 145 EUROPE INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 146 EUROPE INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 147 EUROPE NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 148 EUROPE SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 149 EUROPE NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 150 EUROPE PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 151 EUROPE PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 152 EUROPE DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 153 EUROPE DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 154 EUROPE DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 155 EUROPE PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 156 EUROPE AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 157 EUROPE NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 158 EUROPE NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 159 EUROPE RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 160 U.K. NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 161 U.K. CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 162 U.K. SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 163 U.K. SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 164 U.K. SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 165 U.K. DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 166 U.K. INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 167 U.K. INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 168 U.K. INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 169 U.K. NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 170 U.K. SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 171 U.K. NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 172 U.K. PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 173 U.K. PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 174 U.K. DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 175 U.K. DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 176 U.K. DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 177 U.K. PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 178 U.K. AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 179 U.K. NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 180 U.K. NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 181 U.K. RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 182 GERMANY NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 183 GERMANY CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 184 GERMANY SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 185 GERMANY SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 186 GERMANY SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 187 GERMANY DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 188 GERMANY INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 189 GERMANY INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 190 GERMANY INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 191 GERMANY NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 192 GERMANY SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 193 GERMANY NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 194 GERMANY PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 195 GERMANY PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 196 GERMANY DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 197 GERMANY DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 198 GERMANY DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 199 GERMANY PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 200 GERMANY AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 201 GERMANY NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 202 GERMANY NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 203 GERMANY RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 204 FRANCE NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 205 FRANCE CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 206 FRANCE SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 207 FRANCE SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 208 FRANCE SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 209 FRANCE DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 210 FRANCE INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 211 FRANCE INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 212 FRANCE INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 213 FRANCE NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 214 FRANCE SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 215 FRANCE NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 216 FRANCE PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 217 FRANCE PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 218 FRANCE DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 219 FRANCE DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 220 FRANCE PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 221 FRANCE AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 222 FRANCE NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 223 FRANCE NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 224 FRANCE RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 225 SPAIN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 226 SPAIN CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 227 SPAIN SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 228 SPAIN SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 229 SPAIN SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 230 SPAIN DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 231 SPAIN INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 232 SPAIN INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 233 SPAIN INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 234 SPAIN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 235 SPAIN SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 236 SPAIN NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 237 SPAIN PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 238 SPAIN PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 239 SPAIN DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 240 SPAIN DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 241 SPAIN DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 242 SPAIN PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 243 SPAIN AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 244 SPAIN NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 245 SPAIN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 246 SPAIN RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 247 ITALY NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 248 ITALY CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 249 ITALY SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 250 ITALY SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 251 ITALY SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 252 ITALY DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 253 ITALY INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 254 ITALY INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 255 ITALY INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 256 ITALY NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 257 ITALY SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 258 ITALY NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 259 ITALY PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 260 ITALY PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 261 ITALY DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 262 ITALY DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 263 ITALY DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 264 ITALY PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 265 ITALY AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 266 ITALY NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 267 ITALY NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 268 ITALY RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 269 BELGIUM NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 270 BELGIUM CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 271 BELGIUM SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 272 BELGIUM SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 273 BELGIUM SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 274 BELGIUM DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 275 BELGIUM INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 276 BELGIUM INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 277 BELGIUM INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 278 BELGIUM NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 279 BELGIUM SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 280 BELGIUM NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 281 BELGIUM PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 282 BELGIUM PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 283 BELGIUM DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 284 BELGIUM DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 285 BELGIUM DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 286 BELGIUM PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 287 BELGIUM AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 288 BELGIUM NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 289 BELGIUM NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 290 BELGIUM RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 291 RUSSIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 292 RUSSIA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 293 RUSSIA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 294 RUSSIA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 295 RUSSIA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 296 RUSSIA DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 297 RUSSIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 298 RUSSIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 299 RUSSIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 300 RUSSIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 301 RUSSIA SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 302 RUSSIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 303 RUSSIA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 304 RUSSIA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 305 RUSSIA DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 306 RUSSIA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 307 RUSSIA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 308 RUSSIA PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 309 RUSSIA AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 310 RUSSIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 311 RUSSIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 312 RUSSIA RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 313 SWITZERLAND NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 314 SWITZERLAND CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 315 SWITZERLAND SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 316 SWITZERLAND SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 317 SWITZERLAND SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 318 SWITZERLAND DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 319 SWITZERLAND INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 320 SWITZERLAND INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 321 SWITZERLAND INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 322 SWITZERLAND NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 323 SWITZERLAND SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 324 SWITZERLAND NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 325 SWITZERLAND PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 326 SWITZERLAND PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 327 SWITZERLAND DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 328 SWITZERLAND DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 329 SWITZERLAND DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 330 SWITZERLAND PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 331 SWITZERLAND AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 332 SWITZERLAND NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 333 SWITZERLAND NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 334 SWITZERLAND RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 335 NETHERLANDS NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 336 NETHERLANDS CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 337 NETHERLANDS SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 338 NETHERLANDS SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 339 NETHERLANDS SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 340 NETHERLANDS DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 341 NETHERLANDS INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 342 NETHERLANDS INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 343 NETHERLANDS INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 344 NETHERLANDS NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 345 NETHERLANDS SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 346 NETHERLANDS NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 347 NETHERLANDS PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 348 NETHERLANDS PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 349 NETHERLANDS DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 350 NETHERLANDS DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 351 NETHERLANDS DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 352 NETHERLANDS PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 353 NETHERLANDS AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 354 NETHERLANDS NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 355 NETHERLANDS NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 356 NETHERLANDS RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 357 TURKEY NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 358 TURKEY CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 359 TURKEY SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 360 TURKEY SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 361 TURKEY SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 362 TURKEY DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 363 TURKEY INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 364 TURKEY INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 365 TURKEY INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 366 TURKEY NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 367 TURKEY SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 368 TURKEY NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 369 TURKEY PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 370 TURKEY PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 371 TURKEY DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 372 TURKEY DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 373 TURKEY DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 374 TURKEY PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 375 TURKEY AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 376 TURKEY NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 377 TURKEY NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 378 TURKEY RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 379 REST OF EUROPE NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 380 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
TABLE 381 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 382 ASIA-PACIFIC CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 383 ASIA-PACIFIC SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 384 ASIA-PACIFIC SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 385 ASIA-PACIFIC SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 386 ASIA-PACIFIC DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 387 ASIA-PACIFIC INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 388 ASIA-PACIFIC INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 389 ASIA-PACIFIC INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 390 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 391 ASIA-PACIFIC SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 392 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 393 ASIA-PACIFIC PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 394 ASIA-PACIFIC PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 395 ASIA-PACIFIC DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 396 ASIA-PACIFIC DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 397 ASIA-PACIFIC DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 398 ASIA-PACIFIC PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 399 ASIA-PACIFIC AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 400 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 401 ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 402 ASIA-PACIFIC RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 403 CHINA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 404 CHINA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 405 CHINA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 406 CHINA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 407 CHINA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 408 CHINA DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 409 CHINA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 410 CHINA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 411 CHINA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 412 CHINA NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 413 CHINA SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 414 CHINA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 415 CHINA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 416 CHINA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 417 CHINA DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 418 CHINA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 419 CHINA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 420 CHINA PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 421 CHINA AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 422 CHINA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 423 CHINA NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 424 CHINA RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 425 AUSTRALIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 426 AUSTRALIA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 427 AUSTRALIA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 428 AUSTRALIA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 429 AUSTRALIA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 430 AUSTRALIA DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 431 AUSTRALIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 432 AUSTRALIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 433 AUSTRALIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 434 AUSTRALIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 435 AUSTRALIA SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 436 AUSTRALIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 437 AUSTRALIA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 438 AUSTRALIA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 439 AUSTRALIA DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 440 AUSTRALIA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 441 AUSTRALIA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 442 AUSTRALIA PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 443 AUSTRALIA AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 444 AUSTRALIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 445 AUSTRALIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 446 AUSTRALIA RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 447 JAPAN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 448 JAPAN CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 449 JAPAN SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 450 JAPAN SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 451 JAPAN SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 452 JAPAN DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 453 JAPAN INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 454 JAPAN INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 455 JAPAN INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 456 JAPAN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 457 JAPAN SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 458 JAPAN NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 459 JAPAN PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 460 JAPAN PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 461 JAPAN DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 462 JAPAN DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 463 JAPAN DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 464 JAPAN PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 465 JAPAN AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 466 JAPAN NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 467 JAPAN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 468 JAPAN RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 469 INDIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 470 INDIA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 471 INDIA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 472 INDIA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 473 INDIA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 474 INDIA DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 475 INDIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 476 INDIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 477 INDIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 478 INDIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 479 INDIA SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 480 INDIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 481 INDIA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 482 INDIA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 483 INDIA DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 484 INDIA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 485 INDIA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 486 INDIA PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 487 INDIA AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 488 INDIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 489 INDIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 490 INDIA RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 491 SINGAPORE NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 492 SINGAPORE CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 493 SINGAPORE SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 494 SINGAPORE SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 495 SINGAPORE SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 496 SINGAPORE DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 497 SINGAPORE INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 498 SINGAPORE INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 499 SINGAPORE INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 500 SINGAPORE NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 501 SINGAPORE SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 502 SINGAPORE NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 503 SINGAPORE PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 504 SINGAPORE PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 505 SINGAPORE DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 506 SINGAPORE DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 507 SINGAPORE DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 508 SINGAPORE PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 509 SINGAPORE AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 510 SINGAPORE NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 511 SINGAPORE NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 512 SINGAPORE RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 513 SOUTH KOREA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 514 SOUTH KOREA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 515 SOUTH KOREA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 516 SOUTH KOREA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 517 SOUTH KOREA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 518 SOUTH KOREA DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 519 SOUTH KOREA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 520 SOUTH KOREA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 521 SOUTH KOREA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 522 SOUTH KOREA NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 523 SOUTH KOREA SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 524 SOUTH KOREA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 525 SOUTH KOREA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 526 SOUTH KOREA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 527 SOUTH KOREA DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 528 SOUTH KOREA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 529 SOUTH KOREA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 530 SOUTH KOREA PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 531 SOUTH KOREA AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 532 SOUTH KOREA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 533 SOUTH KOREA NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 534 SOUTH KOREA RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 535 MALAYSIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 536 MALAYSIA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 537 MALAYSIA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 538 MALAYSIA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 539 MALAYSIA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 540 MALAYSIA DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 541 MALAYSIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 542 MALAYSIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 543 MALAYSIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 544 MALAYSIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 545 MALAYSIA SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 546 MALAYSIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 547 MALAYSIA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 548 MALAYSIA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 549 MALAYSIA DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 550 MALAYSIA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 551 MALAYSIA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 552 MALAYSIA PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 553 MALAYSIA AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 554 MALAYSIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 555 MALAYSIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 556 MALAYSIA RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 557 THAILAND NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 558 THAILAND CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 559 THAILAND SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 560 THAILAND SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 561 THAILAND SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 562 THAILAND DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 563 THAILAND INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 564 THAILAND INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 565 THAILAND INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 566 THAILAND NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 567 THAILAND SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 568 THAILAND NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 569 THAILAND PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 570 THAILAND PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 571 THAILAND DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 572 THAILAND DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 573 THAILAND DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 574 THAILAND PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 575 THAILAND AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 576 THAILAND NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 577 THAILAND NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 578 THAILAND RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 579 INDONESIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 580 INDONESIA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 581 INDONESIA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 582 INDONESIA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 583 INDONESIA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 584 INDONESIA DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 585 INDONESIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 586 INDONESIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 587 INDONESIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 588 INDONESIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 589 INDONESIA SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 590 INDONESIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 591 INDONESIA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 592 INDONESIA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 593 INDONESIA DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 594 INDONESIA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 595 INDONESIA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 596 INDONESIA PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 597 INDONESIA AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 598 INDONESIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 599 INDONESIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 600 INDONESIA RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 601 PHILIPPINES NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 602 PHILIPPINES CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 603 PHILIPPINES SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 604 PHILIPPINES SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 605 PHILIPPINES SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 606 PHILIPPINES DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 607 PHILIPPINES INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 608 PHILIPPINES INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 609 PHILIPPINES INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 610 PHILIPPINES NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 611 PHILIPPINES SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 612 PHILIPPINES NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 613 PHILIPPINES PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 614 PHILIPPINES PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 615 PHILIPPINES DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 616 PHILIPPINES DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 617 PHILIPPINES DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 618 PHILIPPINES PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 619 PHILIPPINES AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 620 PHILIPPINES NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 621 PHILIPPINES NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 622 PHILIPPINES RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 623 REST OF ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 624 SOUTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
TABLE 625 SOUTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 626 SOUTH AMERICA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 627 SOUTH AMERICA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 628 SOUTH AMERICA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 629 SOUTH AMERICA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 630 SOUTH AMERICA DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 631 SOUTH AMERICA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 632 SOUTH AMERICA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 633 SOUTH AMERICA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 634 SOUTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 635 SOUTH AMERICA SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 636 SOUTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 637 SOUTH AMERICA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 638 SOUTH AMERICA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 639 SOUTH AMERICA DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 640 SOUTH AMERICA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 641 SOUTH AMERICA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 642 SOUTH AMERICA PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 643 SOUTH AMERICA AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 644 SOUTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 645 SOUTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 646 SOUTH AMERICA RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 647 BRAZIL NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 648 BRAZIL CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 649 BRAZIL SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 650 BRAZIL SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 651 BRAZIL SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 652 BRAZIL DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 653 BRAZIL INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 654 BRAZIL INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 655 BRAZIL INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 656 BRAZIL NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 657 BRAZIL SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 658 BRAZIL NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 659 BRAZIL PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 660 BRAZIL PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 661 BRAZIL DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 662 BRAZIL DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 663 BRAZIL DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 664 BRAZIL PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 665 BRAZIL AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 666 BRAZIL NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 667 BRAZIL NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 668 BRAZIL RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 669 ARGENTINA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 670 ARGENTINA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 671 ARGENTINA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 672 ARGENTINA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 673 ARGENTINA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 674 ARGENTINA DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 675 ARGENTINA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 676 ARGENTINA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 677 ARGENTINA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 678 ARGENTINA NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 679 ARGENTINA SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 680 ARGENTINA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 681 ARGENTINA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 682 ARGENTINA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 683 ARGENTINA DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 684 ARGENTINA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 685 ARGENTINA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 686 ARGENTINA PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 687 ARGENTINA AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 688 ARGENTINA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 689 ARGENTINA NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 690 ARGENTINA RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 691 REST OF SOUTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 692 MIDDLE EAST AND AFRICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
TABLE 693 MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 694 MIDDLE EAST & AFRICA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 695 MIDDLE EAST & AFRICA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 696 MIDDLE EAST & AFRICA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 697 MIDDLE EAST & AFRICA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 698 MIDDLE EAST & AFRICA DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 699 MIDDLE EAST & AFRICA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 700 MIDDLE EAST & AFRICA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 701 MIDDLE EAST & AFRICA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 702 MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 703 MIDDLE EAST & AFRICA SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 704 MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 705 MIDDLE EAST & AFRICA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 706 MIDDLE EAST & AFRICA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 707 MIDDLE EAST & AFRICA DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 708 MIDDLE EAST & AFRICA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 709 MIDDLE EAST & AFRICA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 710 MIDDLE EAST & AFRICA PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 711 MIDDLE EAST & AFRICA AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 712 MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 713 MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 714 MIDDLE EAST & AFRICA RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 715 SOUTH AFRICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 716 SOUTH AFRICA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 717 SOUTH AFRICA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 718 SOUTH AFRICA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 719 SOUTH AFRICA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 720 SOUTH AFRICA DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 721 SOUTH AFRICA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 722 SOUTH AFRICA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 723 SOUTH AFRICA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 724 SOUTH AFRICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 725 SOUTH AFRICA SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 726 SOUTH AFRICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 727 SOUTH AFRICA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 728 SOUTH AFRICA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 729 SOUTH AFRICA DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 730 SOUTH AFRICA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 731 SOUTH AFRICA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 732 SOUTH AFRICA PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 733 SOUTH AFRICA AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 734 SOUTH AFRICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 735 SOUTH AFRICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 736 SOUTH AFRICA RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 737 SAUDI ARABIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 738 SAUDI ARABIA CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 739 SAUDI ARABIA SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 740 SAUDI ARABIA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 741 SAUDI ARABIA SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 742 SAUDI ARABIA DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 743 SAUDI ARABIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 744 SAUDI ARABIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 745 SAUDI ARABIA INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 746 SAUDI ARABIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 747 SAUDI ARABIA SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 748 SAUDI ARABIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 749 SAUDI ARABIA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 750 SAUDI ARABIA PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 751 SAUDI ARABIA DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 752 SAUDI ARABIA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 753 SAUDI ARABIA DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 754 SAUDI ARABIA PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 755 SAUDI ARABIA AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 756 SAUDI ARABIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 757 SAUDI ARABIA NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 758 SAUDI ARABIA RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 759 U.A.E. NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 760 U.A.E. CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 761 U.A.E. SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 762 U.A.E. SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 763 U.A.E. SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 764 U.A.E. DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 765 U.A.E. INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 766 U.A.E. INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 767 U.A.E. INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 768 U.A.E. NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 769 U.A.E. SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 770 U.A.E. NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 771 U.A.E. PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 772 U.A.E. PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 773 U.A.E. DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 774 U.A.E. DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 775 U.A.E. DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 776 U.A.E. PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 777 U.A.E. AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 778 U.A.E. NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 779 U.A.E. NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 780 U.A.E. RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 781 EGYPT NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 782 EGYPT CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 783 EGYPT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 784 EGYPT SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 785 EGYPT SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 786 EGYPT DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 787 EGYPT INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 788 EGYPT INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 789 EGYPT INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 790 EGYPT NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 791 EGYPT SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 792 EGYPT NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 793 EGYPT PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 794 EGYPT PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 795 EGYPT DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 796 EGYPT DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 797 EGYPT DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 798 EGYPT PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 799 EGYPT AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 800 EGYPT NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 801 EGYPT NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 802 EGYPT RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 803 ISRAEL NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 804 ISRAEL CONSUMABLES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 805 ISRAEL SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 806 ISRAEL SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY SAMPLE, 2022-2031 (USD MILLION)
TABLE 807 ISRAEL SEQUENCING SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY METHOD, 2022-2031 (USD MILLION)
TABLE 808 ISRAEL DATA MANAGEMENT SERVICES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
TABLE 809 ISRAEL INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODALITY, 2022-2031 (USD MILLION)
TABLE 810 ISRAEL INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY MODE, 2022-2031 (USD MILLION)
TABLE 811 ISRAEL INSTRUMENTS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 812 ISRAEL NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 813 ISRAEL SEQUENCING BY SYNTHESIS (SBS) IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 814 ISRAEL NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 815 ISRAEL PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 816 ISRAEL PHARMACEUTICALS MICROBIOLOGY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 817 ISRAEL DRUG & BIOMARKER DISCOVERY IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 818 ISRAEL DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 819 ISRAEL DIAGNOSTICS IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 820 ISRAEL PRECISION MEDICINE IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 821 ISRAEL AGRICULTURAL & ANIMAL RESEARCH IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 822 ISRAEL NEXT GENERATION SEQUENCING (NGS) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 823 ISRAEL NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 824 ISRAEL RETAIL SALES IN NEXT GENERATION SEQUENCING (NGS) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 825 REST OF MIDDLE EAST AND AFRICA NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT & SERVICE, 2022-2031 (USD MILLION)
Abbildungsverzeichnis
FIGURE 1 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: SEGMENTATION
FIGURE 2 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: DATA TRIANGULATION
FIGURE 3 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: DROC ANALYSIS
FIGURE 4 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
FIGURE 5 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 8 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: DBMR MARKET POSITION GRID
FIGURE 9 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: SEGMENTATION
FIGURE 11 INCREASING ADOPTION OF NGS-BASED TESTS IN ONCOLOGY, PRENATAL SCREENING, AND INFECTIOUS DISEASE SURVEILLANCE IS DRIVING THE GROWTH OF THE GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET FROM 2024 TO 2031
FIGURE 12 THE PRODUCT AND SERVICE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET IN 2024 AND 2031
FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2024 TO 2031
FIGURE 14 ASIA-PACIFIC IS THE FASTEST-GROWING REGION FOR NEXT GENERATION SEQUENCING (NGS) MARKET MANUFACTURERS IN THE FORECAST PERIOD OF 2024 TO 2031
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET
FIGURE 16 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: BY PRODUCT AND SERVICE 2023
FIGURE 17 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: BY PRODUCT AND SERVICES, 2024-2031 (USD MILLION)
FIGURE 18 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: BY PRODUCT AND SERVICE, CAGR (2024-2031)
FIGURE 19 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET BY PRODUCT AND SERVICE, LIFELINE CURVE
FIGURE 20 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: BY TECHNOLOGY 2023
FIGURE 21 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: BY TECHNOLOG, 2024-2031 (USD MILLION)
FIGURE 22 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: BY TECHNOLOG, CAGR (2024-2031)
FIGURE 23 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET BY TECHNOLOG, LIFELINE CURVE
FIGURE 24 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET : BY APPLICATION, 2023
FIGURE 25 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET : BY APPLICATION, 2024-2031 (USD MILLION)
FIGURE 26 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET : BY APPLICATION, CAGR (2024-2031)
FIGURE 27 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET : BY APPLICATION, LIFELINE CURVE
FIGURE 28 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET : BY END USER, 2023
FIGURE 29 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET : BY END USER, 2024-2031 (USD MILLION)
FIGURE 30 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET : BY END USER, CAGR (2024-2031)
FIGURE 31 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET : BY END USER, LIFELINE CURVE
FIGURE 32 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET : BY DISTRIBUTION CHANNEL, 2023
FIGURE 33 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET : BY DISTRIBUTION CHANNEL, 2024-2031 (USD MILLION)
FIGURE 34 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET : BY DISTRIBUTION CHANNEL, CAGR (2024-2031)
FIGURE 35 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET : BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 36 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: SNAPSHOT (2023)
FIGURE 37 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: COMPANY SHARE 2023 (%)
FIGURE 38 NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET: COMPANY SHARE 2023 (%)
FIGURE 39 EUROPE NEXT GENERATION SEQUENCING (NGS) MARKET: COMPANY SHARE 2023 (%)
FIGURE 40 AISA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET: COMPANY SHARE 2023 (%)
Forschungsmethodik
Die Datenerfassung und Basisjahresanalyse werden mithilfe von Datenerfassungsmodulen mit großen Stichprobengrößen durchgeführt. Die Phase umfasst das Erhalten von Marktinformationen oder verwandten Daten aus verschiedenen Quellen und Strategien. Sie umfasst die Prüfung und Planung aller aus der Vergangenheit im Voraus erfassten Daten. Sie umfasst auch die Prüfung von Informationsinkonsistenzen, die in verschiedenen Informationsquellen auftreten. Die Marktdaten werden mithilfe von marktstatistischen und kohärenten Modellen analysiert und geschätzt. Darüber hinaus sind Marktanteilsanalyse und Schlüsseltrendanalyse die wichtigsten Erfolgsfaktoren im Marktbericht. Um mehr zu erfahren, fordern Sie bitte einen Analystenanruf an oder geben Sie Ihre Anfrage ein.
Die wichtigste Forschungsmethodik, die vom DBMR-Forschungsteam verwendet wird, ist die Datentriangulation, die Data Mining, die Analyse der Auswirkungen von Datenvariablen auf den Markt und die primäre (Branchenexperten-)Validierung umfasst. Zu den Datenmodellen gehören ein Lieferantenpositionierungsraster, eine Marktzeitlinienanalyse, ein Marktüberblick und -leitfaden, ein Firmenpositionierungsraster, eine Patentanalyse, eine Preisanalyse, eine Firmenmarktanteilsanalyse, Messstandards, eine globale versus eine regionale und Lieferantenanteilsanalyse. Um mehr über die Forschungsmethodik zu erfahren, senden Sie eine Anfrage an unsere Branchenexperten.
Anpassung möglich
Data Bridge Market Research ist ein führendes Unternehmen in der fortgeschrittenen formativen Forschung. Wir sind stolz darauf, unseren bestehenden und neuen Kunden Daten und Analysen zu bieten, die zu ihren Zielen passen. Der Bericht kann angepasst werden, um Preistrendanalysen von Zielmarken, Marktverständnis für zusätzliche Länder (fordern Sie die Länderliste an), Daten zu klinischen Studienergebnissen, Literaturübersicht, Analysen des Marktes für aufgearbeitete Produkte und Produktbasis einzuschließen. Marktanalysen von Zielkonkurrenten können von technologiebasierten Analysen bis hin zu Marktportfoliostrategien analysiert werden. Wir können so viele Wettbewerber hinzufügen, wie Sie Daten in dem von Ihnen gewünschten Format und Datenstil benötigen. Unser Analystenteam kann Ihnen auch Daten in groben Excel-Rohdateien und Pivot-Tabellen (Fact Book) bereitstellen oder Sie bei der Erstellung von Präsentationen aus den im Bericht verfügbaren Datensätzen unterstützen.
